Leukotriene Modifier vs Inhaled Corticosteroid in Mild-to-Moderate Asthma

Kaliner, 1985, Mechanisms of glucocorticosteroid action in bronchial asthma, J Allergy Clin Immunol, 76, 321, 10.1016/0091-6749(85)90648-7 Ryan, 1985, Effect of beclomethasone dipropionate on bronchial responsiveness to histamine in controlled nonsteroid-dependent asthma, J Allergy Clin Immunol, 75, 25, 10.1016/0091-6749(85)90007-7 Kraan, 1985, Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline, J Allergy Clin Immunol, 76, 628, 10.1016/0091-6749(85)90786-9 Laitinen, 1991, Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroid, Am Rev Respir Dis, 143, 423, 10.1164/ajrccm/143.2.423 National Asthma Education and Prevention Program, 1997 Lipworth, 1999, Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis, Arch Intern Med, 159, 941, 10.1001/archinte.159.9.941 Laviolette, 1999, Montelukast added to inhaled beclomethasone in treatment of asthma: Montelukast/Beclomethasone Additivity Group, Am J Respir Crit Care Med, 160, 1862, 10.1164/ajrccm.160.6.9803042 Dempsey, 2002, Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma, Chest, 122, 151, 10.1378/chest.122.1.151 Pin, 1992, Use of induced sputum cell counts to investigate airway inflammation in asthma, Thorax, 47, 25, 10.1136/thx.47.1.25 Pauwels, 1997, Effect of inhaled formoterol and budesonide on exacerbations of asthma: Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group, N Engl J Med, 337, 1405, 10.1056/NEJM199711133372001 O'Connell, 2002, Efficacy of budesonide in moderate to severe asthma, Clin Ther, 24, 887, 10.1016/S0149-2918(02)80005-4 Ward, 2002, Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma, Thorax, 57, 309, 10.1136/thorax.57.4.309 Fahy, 1995, Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects, Am J Respir Crit Care Med, 152, 53, 10.1164/ajrccm.152.1.7599862 Park, 1998, Eosinophil count and eosinophil cationic protein concentration of induced sputum in the diagnosis and assessment of airway inflammation in bronchial asthma, Allergy Asthma Proc, 19, 61, 10.2500/108854188778607255 Fujimoto, 1999, Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema, Chest, 115, 697, 10.1378/chest.115.3.697 Tarodo de la Fuente, 1999, Eosinophilic inflammation assessed by induced sputum in corticosteroid- dependent asthma, Respir Med, 93, 183, 10.1016/S0954-6111(99)90006-9 Ulrik, 1993, Bronchial responsiveness to inhaled histamine in both adults with intrinsic and extrinsic asthma: the importance of prechallenge forced expiratory volume in 1 second, J Allergy Clin Immunol, 91, 120, 10.1016/0091-6749(93)90304-X Popp, 1994, Factors contributing to the occurrence and predictability of bronchial hyperresponsiveness to methacholine in children, J Allergy Clin Immunol, 93, 735, 10.1016/0091-6749(94)90253-4 Sterk, 2002, Airway hyperresponsiveness: using bronchial challenge tests in research and management of asthma, J Aerosol Med, 15, 123, 10.1089/089426802320282248 Sont, 1999, Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment: The AMPUL Study Group, Am J Respir Crit Care Med, 159, 1043, 10.1164/ajrccm.159.4.9806052